The combined serum levels of miR‐375 and urokinase plasminogen activator receptor are suggested as diagnostic and prognostic biomarkers in prostate cancer

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0215|137|6|1406-1416

ISSN： 0020-7136

Source： INTERNATIONAL JOURNAL OF CANCER, Vol.137, Iss.6, 2015-09, pp. : 1406-1416

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Diagnostic performance of expression of PCA3, Hepsin and miR biomarkers inejaculate in combination with serum PSA for the detection of prostate cancer

By  

THE PROSTATE, Vol. 75, Iss. 5, 2015-04 ,pp. : 539-549

John Wiley & Sons Inc

Access to resources Recommend Favorite

Serum soluble urokinase plasminogen activator receptor as a screening test for the early diagnosis of hepatocellular carcinoma

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 2, 2015-02 ,pp. : 601-607

John Wiley & Sons Inc

Access to resources Recommend Favorite

Soluble urokinase plasminogen activator receptor levels are elevated and associated with complications in patients with type 1 diabetes

By  

JOURNAL OF INTERNAL MEDICINE, Vol. 277, Iss. 3, 2015-03 ,pp. : 362-371

John Wiley & Sons Inc

Access to resources Recommend Favorite

MiR‐375 and miR‐200c as predictive biomarkers of islet isolation and transplantation in total pancreatectomy with islet autotransplantation

By  

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, Vol. 23, Iss. 9, 2016-09 ,pp. : 585-594

John Wiley & Sons Inc

Access to resources Recommend Favorite

Diagnostic Value of Serum Ghrelin Levels in Prostate Cancer

By  

Urologia Internationalis, Vol. 80, Iss. 3, 2008-05 ,pp. : 245-248

Karger

Access to resources Recommend Favorite